| Date | Title | Description | |
|---|---|---|---|
| 22 Jun 2021 | On significant placements in financial instruments | Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. | Download |
| 22 Jun 2021 | On significant placements in financial instruments | Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. | Download |
| 29 Apr 2021 | On business and financial situation | The Company informs about the increase of its fill-finish capacity for the manufacture of Moderna’s COVID-19 vaccine outside the United States. | Download |
| 12 Apr 2021 | On business and financial situation | The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine. | Download |
| 02 Mar 2021 | On business and financial situation | The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 27 Jul 2020 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors. | Download |
| 27 Jul 2020 | On business and financial situation | ROVI releases the 2020 First Half Results presentation | Download |
| 02 Jul 2020 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the second quarter of 2020 | Download |
| 13 May 2020 | On business and financial situation | ROVI releases the presentation related to the first quarter 2020 financial results | Download |
| 13 May 2020 | Interim Management Report | The company releases the press release related to the 2020 first quarter financial results | Download |